American Journal of Biomedical and Life Sciences

Volume 7, Issue 5, October 2019

  • Profile of Birth Injuries in a Tertiary Hospital in Enugu, Nigeria

    Chukwubuike Kevin Emeka, Ekwochi Uchenna, Enebe Joseph Tochukwu, Nduagubam Obinna Chukwuebuka, Eze Thaddeus Chikaodili, Iheji Chukwunonso Chigozie

    Issue: Volume 7, Issue 5, October 2019
    Pages: 99-103
    Received: 31 August 2019
    Accepted: 16 September 2019
    Published: 7 October 2019
    Abstract: Background: Birth injury is defined as structural damage of a newborn secondary to mechanical forces that occur during labor and/or delivery. This study determined the incidence, risk factors and outcome of birth injury. Methodology: This was an observational study of birth injuries in neonates, over a period of one year, carried out at a tertiary ... Show More
  • Lunar Magnetism Orchestrates Menstrual Cycle in Symphony of Life

    Venkata Subba Rao Yeragudipati

    Issue: Volume 7, Issue 5, October 2019
    Pages: 104-109
    Received: 26 July 2019
    Accepted: 28 August 2019
    Published: 9 October 2019
    Abstract: Female humans have an internal menstrual cycle rhythmicity that helps them anticipate and adapt to the regular rhythm of the Lunar Month and intensity of Moon Light. But how does this menstrual cycle rhythmicity work? This paper presents my discovery elucidating female menstrual cycle rhythmicity and its inner workings with Lunar cycle rhythmicity ... Show More
  • 2-Deoxy-D-glucose Mediates Dihydrodiol Dehydrogenases Over-expression and Cisplatin Resistance in Human Cervical Cancer Cells

    Jianli Chen, Rong Wu, John Zihou Chen, Visitacion Pabicon, Monika Wrzolek, Fiona Simpkins, Henry Simpkins

    Issue: Volume 7, Issue 5, October 2019
    Pages: 110-120
    Received: 30 September 2019
    Accepted: 14 October 2019
    Published: 23 October 2019
    Abstract: Dihydrodiol dehydrogenases (DDHs) belong to a superfamily of cytosolic NADP (H)-dependent oxidoreductases. The over-expression of DDHs induces cisplatin resistance. 2-Deoxy-D-glucose (2-DG), a glucose analogue, is currently being used as an anticancer reagent. In this study we investigated the effect of 2-DG on DDHs expression and cisplatin resista... Show More